April 2018 marks the third anniversary of the launch of DenseBreast-info.org, the educational resource for medically sourced information and legislation focusing on fibroglandular breast density. The organization reports it has had 230,000 site visitors to date.

Philips Healthcare last week issued a proactive advisory warning to its iSite and IntelliSpace picture archiving and communication system (PACS) customers of potential security vulnerabilities in the products. The company cautioned that while it has received no reports of patient harm, the vulnerabilities in question could impact or potentially compromise patient confidentiality, system integrity and/or system availability.

Dicom Systems Inc. recently announced it has deployed its flagship Workflow Unifier platform at the foot of Mount Kilimanjaro in Moshi, Tanzania. The project was funded by the non-profit East Africa Medical Assistance Foundation (EAMAF) which chose the Kilimanjaro Christian Medical Centre (KCMC), a 630-bed referral hospital and medical school, as the recipient site.

Volpara Solutions Inc. and mammography education provider Mammography Educators LLC announced the launch of training videos designed to make mammography positioning better. The training videos have been integrated in Volpara’s VolparaEnterprise software that provides a comprehensive assessment of image quality on every screening mammogram.

Researchers have developed a new imaging agent that could help guide and assess treatments for people with various neurological diseases, including Alzheimer’s, Parkinson’s and multiple sclerosis. The agent, which is used in positron emission tomography (PET) scans, targets receptors in nerve cells in the brain that are involved in learning and memory. The study is featured in the April issue of The Journal of Nuclear Medicine.

New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such. The ACR and SBI now call for all women to have a risk assessment at age 30 to see if screening earlier than age 40 is needed. The societies also newly-recommend that women previously diagnosed with breast cancer be screened with magnetic resonance imaging (MRI).

April 5, 2018 — Myriad Genetic Laboratories Inc. announced that the Japanese Ministry of Health, Labour and Welfare has ...